Therefore, these data provide original, compelling evidence that the combination of HT + metformin is functionally linked to these well-known, patho-physiologically relevant, oncogenic pathways in PCa (the MASPK, AKT, and TGF-b pathways). The gene discussed is AKT1; the disease is posterior cortical atrophy.